Form D · Biotechnology
Prenosis, Inc.
Champaign, IL · CIK 0001668485
Offering snapshot reported Sep 9, 2016 · SEC filing
- Reported sold
- $1.5M Offering amount: $8.85M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 26, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2016 | Initial | $1,500,030 | No comparison | 2 | SEC filing |
| Mar 18, 2016 | Initial | $65,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-270339
Source: Form D, filed Sep 9, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rashid Bashir | Director, Executive |
| Gary Durack | Executive |
| Bobby Reddy | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
210 Hazelwood Dr., Suite 103
Champaign, IL, 61822
Champaign, IL, 61822